UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002287 |
|---|---|
| Receipt number | R000002737 |
| Scientific Title | A phase2 study of Rituximab+THP-COP(R-THP-COP) in elderly subjects with untreated, advanced, CD20-positive, indolent B-cell Non-Hodgkin's lymphoma |
| Date of disclosure of the study information | 2009/08/03 |
| Last modified on | 2016/08/08 14:46:15 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/08/03 15:14:30 | ||
| 2 | Update | 2012/02/06 15:05:56 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2013/08/12 13:10:59 | Organization Organization |
|
| 4 | Update | 2013/08/12 13:18:42 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 5 | Update | 2013/08/15 10:43:50 | Last follow-up date |
|
| 6 | Update | 2016/08/08 14:46:15 | Recruitment status |
